CAR T: Understanding this Exciting New Therapy
Nov 04, 2022 7:00 PM (ET)
CAR T-cell therapy is quickly becoming one of the most talked about new treatments in the field of oncology, but who might be an appropriate patient for this type of therapy? In this session we will talk about what CAR T-cell therapy is, how it works, some of the potential risks and benefits, as well as some considerations around eligibility and access. Attendees will leave this session with a greater understanding of CAR T-cell therapy.
Moderators

Fiona An, MD (she/her/hers)
Executive Director of US Hematology Medical Disease Lead for Multiple Myeloma, Bristol Myers Squibb
View Bio

Dan Platt, MD (he/him/his)
Chief Medical Officer, GRYT Health
View Bio
Speakers

Ben Hernandez II (he/him/his)
Survivor and Advocate
View Bio

Rachel Saks (she/her/hers)
Senior Director of Education, Cancer Support Community
View Bio

Mary Katherine Snow (she/her/hers)
Survivor and Advocate
View Bio